OR
CLICK HERE TO REGISTER AT NO COST
SAVE 20% - 50% ON
Medical Supplies
Additional Information
Description
The Zepbound® (tirzepatide) 2.5 mg/0.5 mL pen is the initial once-weekly starter dose designed for treatment initiation and titration in adults with obesity or overweight with weight-related comorbidities, providing a tolerability ramp-up while introducing the novel mechanism of this dual GIP and GLP-1 receptor agonist, which is proven to reduce appetite and caloric intake through synergistic activation of both the GIP and GLP-1 pathways as part of a comprehensive weight management strategy that includes dietary and behavioral modifications.
You've just added this product to thecart: